ABB Ltd - ABBNY

ABBNY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ABBNY	0.4	3.3	6.3	1.4	6.1	29.7	67.9	135.6	168.4	238.7
S&P 500	-0.0	0.5	4.7	2.8	12.1	22.3	38.9	80.9	191.1	34526.0

Compare ABBNY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ABBNY
name	ABB Ltd
price	57
changes percentage	0.44
change	0.25
day low	56.72
day high	57.10
year high	59.67
year low	45.11
market cap	105085770000
price avg 50	55.86
price avg 200	55.46
exchange	PNK
volume	9737
avg volume	202868
open	57.01
previous close	56.75
eps	2.09
pe	27.27
earnings announcement	2025-04-17T04:00:00.000+0000
shares outstanding	1843610000
timestamp	2025-02-14 17:30:47

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 65.0%

Overall Quarterly Financial Health: 50.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	32235000000	29446000000	9.47
gross profit	11279000000	9710000000	16.16
gross profit ratio	0.35	0.33	6.11
research and development expenses	1317000000	1166000000	12.95
operating expenses	6408000000	6373000000	0.55
interest income	165000000	72000000	129.17
interest expense	275000000	130000000	111.54
ebitda	5833000000	4214000000	38.42
ebitdaratio	0.18	0.15	22.83
operating income	4871000000	3337000000	45.97
operating income ratio	0.15	0.11	33.34
net income	3745000000	2475000000	51.31
net income ratio	0.12	0.08	38.22
eps	2.02	1.3	55.38

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 32,235 million in 2023 from 29,446 million in 2022 representing a change of 9.47%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 11,279 million in 2023 from 9,710 million in 2022 representing a change of 16.16%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 1,317 million in 2023 from 1,166 million in 2022 representing a change of 12.95%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 5,833 million in 2023 from 4,214 million in 2022 representing a change of 38.42%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 4,871 million in 2023 from 3,337 million in 2022 representing a change of 45.97%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,745 million in 2023 from 2,475 million in 2022 representing a change of 51.31%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.02 in 2023 from 2.02 in 2022 representing a change of 55.38%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 6,408 million in 2023 from 6,373 million in 2022 representing a change of 0.55%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	8151000000	8239000000	-1.07
gross profit	3116000000	3174000000	-1.83
gross profit ratio	0.38	0.39	-0.77
research and development expenses	334000000	365000000	-8.49
operating expenses	1807000000	6863000000	-73.67
interest income	43000000	46000000	-6.52
interest expense	41000000	13000000	215.38
ebitda	1559000000	1588000000	-1.83
ebitdaratio	0.19	-0.31	160.96
operating income	1309000000	-3689000000	135.48
operating income ratio	0.16	-0.45	135.87
net income	947000000	1096000000	-13.59
net income ratio	0.12	0.13	-12.66
eps	0.51	0.6	-15.00

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 8,151 million in 2024Q3 from 8,239 million in 2024Q2 representing a change of -1.07%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 3,116 million in 2024Q3 from 3,174 million in 2024Q2 representing a change of -1.83%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 334 million in 2024Q3 from 365 million in 2024Q2 representing a change of -8.49%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,559 million in 2024Q3 from 1,588 million in 2024Q2 representing a change of -1.83%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 0.51 in 2024Q3 from 0.51 in 2024Q2 representing a change of -15.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 1,807 million in 2024Q3 from 6,863 million in 2024Q2 representing a change of -73.67%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 1,309 million in 2024Q3 from -3,689 million in 2024Q2 representing a change of 135.48%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 947 million in 2024Q3 from 1,096 million in 2024Q2 representing a change of -13.59%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	40940000000	39148000000	4.58
total liabilities	26794000000	25876000000	3.55
total equity	14146000000	13272000000	6.59
cash and cash equivalents	3891000000	4156000000	-6.38
short term investments	1928000000	725000000	165.93
long term investments	187000000	130000000	43.85
total current assets	21277000000	19570000000	8.72
total non current assets	19663000000	19578000000	0.43
total current liabilities	18004000000	16529000000	8.92
total non current liabilities	8790000000	9347000000	-5.96
common stock	163000000	171000000	-4.68
retained earnings	19724000000	20082000000	-1.78
total debt	8743000000	8549000000	2.27

Overall Score of Annual Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 40,940 million in 2023 from 39,148 million in 2022 representing a change of 4.58%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 14,146 million in 2023 from 13,272 million in 2022 representing a change of 6.59%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 1,928 million in 2023 from 725 million in 2022 representing a change of 165.93%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 21,277 million in 2023 from 19,570 million in 2022 representing a change of 8.72%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 26,794 million in 2023 from 25,876 million in 2022 representing a change of 3.55%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 3,891 million in 2023 from 4,156 million in 2022 representing a change of -6.38%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 18,004 million in 2023 from 16,529 million in 2022 representing a change of 8.92%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 163 in 2023 from 171 in 2022 representing a change of -4.68%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 19,724 million in 2023 from 20,082 million in 2022 representing a change of -1.78%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 8,743 million in 2023 from 8,549 million in 2022 representing a change of 2.27%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	40684000000	39281000000	3.57
total liabilities	25924000000	25135000000	3.14
total equity	14760000000	14146000000	4.34
cash and cash equivalents	3264000000	1617000000	101.86
short term investments	1334000000	2651000000	-49.68
long term investments	-1149000000	219000000	-624.66
total current assets	20832000000	19841000000	4.99
total non current assets	19852000000	19440000000	2.12
total current liabilities	15477000000	15054000000	2.81
total non current liabilities	10447000000	10081000000	3.63
common stock	162000000	162000000	0.00
retained earnings	19730000000	18783000000	5.04
total debt	7670000000	7634000000	0.47

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 40,684 million in 2024Q3 from 39,281 million in 2024Q2 representing a change of 3.57%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 14,760 million in 2024Q3 from 14,146 million in 2024Q2 representing a change of 4.34%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 3,264 million in 2024Q3 from 1,617 million in 2024Q2 representing a change of 101.86%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 20,832 million in 2024Q3 from 19,841 million in 2024Q2 representing a change of 4.99%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 19,730 million in 2024Q3 from 18,783 million in 2024Q2 representing a change of 5.04%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 25,924 million in 2024Q3 from 25,135 million in 2024Q2 representing a change of 3.14%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 1,334 million in 2024Q3 from 2,651 million in 2024Q2 representing a change of -49.68%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 15,477 million in 2024Q3 from 15,054 million in 2024Q2 representing a change of 2.81%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 7,670 million in 2024Q3 from 7,634 million in 2024Q2 representing a change of 0.47%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-265000000	-315000000	15.87
operating cash flow	4290000000	1287000000	233.33
free cash flow	3520000000	525000000	570.48
capital expenditure	-770000000	-762000000	-1.05
depreciation and amortization	780000000	814000000	-4.18
deferred income tax	-25000000	-348000000	92.82
stock based compensation	0	42000000	-100.00
accounts payables	-106000000	395000000	-126.84
inventory	-3000000	-1599000000	99.81
acquisitions net	328000000	1253000000	-73.82
investments in property plant and equipment	-770000000	-762000000	-1.05
net cash used for investing activites	-1615000000	981000000	-264.63
debt repayment	-346000000	1146000000	-130.19
common stock issued	154000000	610000000	-74.75
common stock repurchased	-1258000000	-3553000000	64.59
dividends paid	-1713000000	-1698000000	-0.88
net cash used provided by financing activities	-2897000000	-2394000000	-21.01
cash at end of period	3909000000	4174000000	-6.35
accounts receivables	-661000000	-831000000	20.46
cash at beginning of period	4174000000	4489000000	-7.02

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -265 million in 2023 from -315 million in 2022 representing a change of 15.87%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 4,290 million in 2023 from 1,287 million in 2022 representing a change of 233.33%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 3,520 million in 2023 from 525 million in 2022 representing a change of 570.48%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -770 million in 2023 from -762 million in 2022 representing a change of -1.05%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 42 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 106 million in 2023 from 395 million in 2022 representing a change of -126.84%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -25 million in 2023 from -348 million in 2022 representing a change of 92.82%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to -661 in 2023 from -831 million in 2022 representing a change of 20.46%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -1,713 million in 2023 from -1,698 million in 2022 representing a change of -0.88%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	1345000000	1067000000	26.05
free cash flow	1149000000	882000000	30.27
capital expenditure	-196000000	-185000000	-5.95
depreciation and amortization	194000000	202000000	-3.96
deferred income tax	0	28000000	-100.00
stock based compensation	0	0	NaN
accounts receivables	229000000	-146000000	256.85
accounts payables	-119000000	116000000	-202.59
inventory	-113000000	-106000000	-6.60
acquisitions net	-168000000	-68000000	-147.06
investments in property plant and equipment	-196000000	-185000000	-5.95
net cash used for investing activites	-511000000	651000000	-178.49
debt repayment	-336000000	-1566999999	78.56
common stock issued	14000000	0	NaN
common stock repurchased	-280000000	-272000000	-2.94
dividends paid	0	-850000000	100.00
net cash used provided by financing activities	-582000000	-2835000000	79.47
net change in cash	304000000	314000000	-3.18
cash at end of period	3283000000	1617000000	103.03
cash at beginning of period	2979000000	1303000000	128.63

Overall Score of Quarterly Cashflow Statement

0.57 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 304 million in 2024Q3 from 314 million in 2024Q2 representing a change of -3.18%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables increased to 119 million in 2024Q3 from 116 million in 2024Q2 representing a change of -202.59%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 229 in 2024Q3 from -146 million in 2024Q2 representing a change of 256.85%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 1,345 million in 2024Q3 from 1,067 million in 2024Q2 representing a change of 26.05%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,149 million in 2024Q3 from 882 million in 2024Q2 representing a change of 30.27%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -196 million in 2024Q3 from -185 million in 2024Q2 representing a change of -5.95%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -850 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	17.39	15.51	12.13
net income per share	2.02	1.3	54.99
operating cash flow per share	2.31	0.68	241.43
free cash flow per share	1.9	0.28	586.76
cash per share	3.14	2.57	22.11
book value per share	7.63	6.99	9.17
tangible book value per share	1.27	0.71	78.55
shareholders equity per share	7.23	6.73	7.50
interest debt per share	4.86	4.57	6.43
market cap	82243333191.31	57623415516.0	42.73
enterprise value	87095333191.31	62016415516.0	40.44
pe ratio	21.96	23.28	-5.68
price to sales ratio	2.55	1.96	30.38
pocfratio	19.17	44.77	-57.18
pfcf ratio	23.36	109.76	-78.71
pb ratio	6.13	4.51	35.99
ptb ratio	6.13	4.51	35.99
ev to sales	2.7	2.11	28.29
enterprise value over ebitda	14.93	14.3	4.44
ev to operating cash flow	20.3	48.19	-57.87
ev to free cash flow	24.74	118.13	-79.05
earnings yield	0.05	0.04	6.02
free cash flow yield	0.04	0.01	369.77
debt to equity	0.65	0.67	-2.56
debt to assets	0.21	0.22	-2.21
net debt to ebitda	0.83	1.01	-17.86
current ratio	1.18	1.18	-0.18
interest coverage	17.71	25.67	-31.00
income quality	1.15	0.49	134.71
dividend yield	0.02	0.03	-29.32
payout ratio	0.46	0.69	-33.33
sales general and administrative to revenue	0.07	0.06	3.18
research and ddevelopement to revenue	0.04	0.04	3.18
intangibles to total assets	0.29	0.3	-5.44
capex to operating cash flow	0.18	0.59	-69.69
capex to revenue	0.02	0.03	-7.69
capex to depreciation	0.99	0.94	5.45
stock based compensation to revenue	0	0.0	-100.00
graham number	18.13	14.05	29.08
roic	0.15	0.1	48.90
return on tangible assets	0.13	0.09	41.32
graham net net	-6.2	-6.66	6.81
working capital	3273000000	3041000000	7.63
tangible asset value	2362000000	1355000000	74.32
net current asset value	-5517000000	-6306000000	12.51
invested capital	20092000000	19710000000	1.94
average receivables	7830000000	6990500000	12.01
average payables	4875500000	4912500000	-0.75
average inventory	6088500000	5454000000	11.63
days sales outstanding	96.65	88.31	9.45
days payables outstanding	84.16	90.7	-7.20
days of inventory on hand	106.77	111.48	-4.23
receivables turnover	3.78	4.13	-8.64
payables turnover	4.34	4.02	7.76
inventory turnover	3.42	3.27	4.42
roe	0.28	0.19	44.17
capex per share	0.42	0.4	3.50

• Positive

  ROE: Return on Equity (ROE) increased to 0.28 on 2023-12-31 from 0.19 on 2022-12-31, representing a change of 44.17%. Suggesting the company has been generating high returns for its shareholders.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.65 on 2023-12-31 from 0.67 on 2022-12-31, representing a change of -2.56%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 21.96 on 2023-12-31 from 23.28 on 2022-12-31, representing a change of -5.68%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.18 on 2023-12-31 from 1.18 on 2022-12-31, representing a change of -0.18%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
ABBNY
calendar year	2024	2024	NaN
revenue per share	4.42	4.43	-0.26
net income per share	0.51	0.59	-12.89
operating cash flow per share	0.73	0.57	27.08
free cash flow per share	0.62	0.47	31.33
cash per share	2.49	2.28	9.07
book value per share	8.0	7.6	5.19
tangible book value per share	1.7	1.36	25.10
shareholders equity per share	7.63	7.24	5.40
interest debt per share	4.18	4.11	1.66
market cap	106717554621.6	104640528884.3	1.98
enterprise value	111123554621.6	109313528884.3	1.66
pe ratio	28.17	23.87	18.03
price to sales ratio	13.09	12.7	3.09
pocfratio	79.34	98.07	-19.09
pfcf ratio	92.88	118.64	-21.71
pb ratio	7.58	7.77	-2.45
ptb ratio	7.58	7.77	-2.45
ev to sales	13.63	13.27	2.75
enterprise value over ebitda	71.28	68.84	3.55
ev to operating cash flow	82.62	102.45	-19.36
ev to free cash flow	96.71	123.94	-21.97
earnings yield	0.01	0.01	-15.28
free cash flow yield	0.01	0.01	27.74
debt to equity	0.54	0.57	-3.90
debt to assets	0.19	0.19	-2.99
net debt to ebitda	2.83	2.94	-3.96
current ratio	1.35	1.32	2.13
interest coverage	31.93	105.85	-69.84
income quality	1.43	0.97	47.46
dividend yield	0	0.01	-100.00
payout ratio	0	0.78	-100.00
sales general and administrative to revenue	0.17	0.17	-0.76
research and ddevelopement to revenue	0.04	0.04	-7.53
intangibles to total assets	0.29	0.3	-3.42
capex to operating cash flow	0.15	0.17	-15.95
capex to revenue	0.02	0.02	7.09
capex to depreciation	1.01	0.92	10.31
stock based compensation to revenue	0	0	NaN
graham number	9.38	9.79	-4.18
roic	0.04	0.04	-15.77
return on tangible assets	0.03	0.04	-17.75
graham net net	-9.78	-6.07	-61.03
working capital	5355000000	4787000000	11.87
tangible asset value	3142000000	2532000000	24.09
net current asset value	-5092000000	-5294000000	3.82
invested capital	22094000000	21357000000	3.45
average receivables	4305000000	8565000000	-49.74
average payables	5142500000	5068000000	1.47
average inventory	6406500000	6213500000	3.11
days sales outstanding	0	94.05	-100.00
days payables outstanding	92.36	90.94	1.56
days of inventory on hand	117.19	111.18	5.40
receivables turnover	0	0.96	-100.00
payables turnover	0.97	0.99	-1.54
inventory turnover	0.77	0.81	-5.13
roe	0.07	0.08	-17.36
capex per share	0.11	0.1	6.81

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 28.17 on 2024-09-30 Q3 from 23.87 on 2024-06-30 Q2, representing a change of 18.03%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.35 on 2024-09-30 Q3 from 1.32 on 2024-06-30 Q2, representing a change of 2.13%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.54 on 2024-09-30 Q3 from 0.57 on 2024-06-30 Q2, representing a change of -3.90%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 15.84 which is lower than current price 57, indicates the company may be overvalued.